Biologics Drug Discovery Market
Biologics Drug Discovery Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Biologics Drug Discovery Market Size and Growth
The Biologics Drug Discovery market is experiencing significant growth, driven by increasing demand for novel therapies and advancements in biotechnology. The market size is projected to reach approximately $400 billion by 2026, reflecting a compound annual growth rate (CAGR) of 8-10%. Key factors influencing this growth include technological innovations and rising healthcare expenditure. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ GenScript
◍ Roche
◍ Pfizer
◍ Novartis
◍ Sanofi
◍ Merck
◍ GlaxoSmithKline
◍ AstraZeneca
◍ AbbVie
◍ Amgen
◍ Bristol-Myers Squibb
◍ Novo Nordisk
◍ Allergan
◍ Astellas Pharma
◍ Teva Pharmaceutical Industries
The Biologics Drug Discovery Market features companies like GenScript, Roche, Pfizer, and others, focusing on biologic therapies through innovative technologies. They enhance research capabilities, streamline development processes, and expand therapeutic areas. Key players' sales in 2022 include:
- Pfizer: $81.3 billion
- Roche: $62.4 billion
- Merck: $59.4 billion
Market Segmentation
By Application
◍ Hospitals
◍ Clinics
◍ Research Labs
◍ Diagnostic Centers
◍ Others
By Product
◍ Biologicals
◍ Monoclonal Antibodies
◍ Recombinant Proteins
◍ Other Biologics
Request Sample Report
$ 238.42 Billion
Request Sample Report
